Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.【Read More】
Update: 2026-03-05Source: Haiou HealthViews: 125
Ponatinibis a cancer medicine that interferes with the growth of some cancer cells.Ponatinibis used in adults to treat a type of blood cancer called c···【Read More】
Update: 2026-03-05Source: Haiou HealthViews: 119
Apalutamide has been officially launched in China, and patients can obtain the drug through formal medical channels.How to Purchase ApalutamideHospita···【Read More】
Update: 2026-03-05Source: Haiou HealthViews: 127
The latest price of apalutamide in 2026 may vary due to factors such as purchasing channels and exchange rate fluctuations, and the price is not fixed···【Read More】
Update: 2026-03-05Source: Haiou HealthViews: 130
Mektovi is used in combination with another drug called encorafenib (brand name Braftovi) to treat advanced melanoma (skin cancer) and non-small cell ···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 126
Other medications may affect binimetinib, including prescription drugs, over-the-counter drugs, vitamins, and herbal products.Please tell your doctor ···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 112
Strictly follow your doctor's instructions regarding diet, drinks, and activity restrictions.【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 112
Seek immediate emergency medical assistance or call the poisoning helpline.【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 111
Take the missed dose as soon as possible; however, if less than 6 hours have passed since the next dose, skip the missed dose. Never take a double dos···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 111
On June 27, 2018, the U.S. Food and Drug Administration (FDA) approved the combination of encorafenib and binimetinib for the treatment of patients wi···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 108
Binimetinib, developed by Pierre Fabre in France, was approved by the U.S. Food and Drug Administration (FDA) in 2018, providing a new treatment optio···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 113
Binimetinib is often used in combination with encorafenib. These two drugs target the same signaling pathway at different points and can synergistical···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 105
While binimetinib offers a new treatment option for melanoma patients, its potential adverse reactions still require careful monitoring during use.Sid···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 107
Anagrelide is a platelet-reducing agent, also known as a platelet production inhibitor. Domestically produced Anagrelide capsules were launched in Chi···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 114
Anagrelide is a selective platelet-producing inhibitor, approved for marketing in the United States in 1997, and subsequently approved in Europe and o···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 111
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



